9
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Evaluation of Kampo medicines used to treat rheumatoid arthritis in collagen-induced arthritic and pX transgenic mice

, , , &
Pages 50-56 | Received 29 Jan 2002, Accepted 04 Jun 2002, Published online: 02 Jan 2014

References

  • Wakabayashi K, Inoue M, Ogihara Y. The effect of Keishi-bushi-to on collagen-induced arthritis. Biol Pharm Bull 1997;20:376–80.
  • Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857–68.
  • Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedaale B. Immunisation against heterologous type II collagen induces arthri-tis in mice. Nature 1980;283:666–8.
  • Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990;118:193–232.
  • Stuart JM, Townes AS, Kang AH. Type II collagen-induced arthri-tis. Ann NY Acad Sci 1985;460:355–62.
  • Gregersen PK, Silver J, Winchester RJ. The shared epitope hy-pothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30: 1205–13.
  • Iwakura H, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, et al. Induction of inflammatory arthropathy resembling rheuma-toid arthritis in mice transgenic for HTLV-1. Science 1991;253: 1026–8.
  • Yamamoto H, Sekiguchi T, Itagaki K, Saijo S, Iwakura Y. Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthritis Rheum 1993;36:1612–20.
  • Iwakura Y, Saijo S, Kioka Y, Nakayama-Yamada J, Itagaki K, Tosu M, et al. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflamma-tory arthropathy resembling rheumatoid arthritis in humans. J Immunol 1995;155:1588–98.
  • Endo T, Iwakura Y, Kobata A. Structural changes in the N-linked sugar chains of serum immunoglobulin G of HTLV-1 transgenic mice. Biochem Biophys Res Commun 1993;192: 1004.
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Anal Biochem 1982;126:131–8.
  • Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type II collagen-induced murine arthritis. I. Induction and per-petuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988;140:1477–84.
  • Holmdahl R, Jansson L, Larsson A, Jonsson R. Arthritis in DBA/ 1 mice induced with passively transfered type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Imunol 1990;31:147–57.
  • Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH. Serum transfer of collagen-induced arthritis. II. Identification and local-ization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum 1983;26:1237–44.
  • Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcy receptors. J Exp Med 2000;1611–6.
  • Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis: proposed complement C5, major histo-compatibility complex (MHC) and non-MHC loci. J Exp Med 1985;162:1878–91.
  • Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concen-trations of nitrite in synovial fluid and serum samples suggest in-creased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219–22.
  • Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062–9.
  • Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumor necro-sis factor: a predicitive genetic model of arthritits. EMBO J 1991;10:4025–31.
  • Feige U, Karbowski A, Rordorf-Adam C, Pataki A. Arthritis in-duced by continuous infusion of hr-interleukin-lct into the rabbit knee joint. Int J Tissue React 1989;11:225–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.